Item 8.01 Other Events.
On
In accordance with General Instruction B.2 of Form 8-K, the information in this Item 8.01, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits. Exhibit Description 99.1 Press release, datedSeptember 17, 2021 , titled "Protagonist Therapeutics Reports FDA Clinical Hold onRusfertide Clinical Development Program" 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
© Edgar Online, source